Corvus Capital Ltd., 10% Owner, Director at CONDUIT PHARMACEUTICALS INC. (CDT), sold 27,228,412 shares at $0.26 ($8.1M) on 2024-07-17, disclosed to the SEC on 2024-09-19.
Open-market sale of $8.1M CDT by 10% Owner, Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,100,000 | $0 | 0.0% |
| 2 | $0.64 | 1,000 | $640 | 0.0% |
| 3 | $0.51 | 35,923 | $18K | 0.2% |
| 4 | $0.44 | 77,681 | $34K | 0.4% |
| 5 | $0.33 | 150,000 | $50K | 0.6% |
| 6 | $0.29 | 300,000 |
| $87K |
| 1.1% |
| 7 | $0.30 | 582,952 | $175K | 2.2% |
| 8 | $0.30 | 582,952 | $175K | 2.2% |
| 9 | $0.25 | 1,389,820 | $347K | 4.3% |
| 10 | $0.25 | 1,005,200 | $251K | 3.1% |
| 11 | $0.32 | 10,244,392 | $3.3M | 40.5% |
| 12 | $0.32 | 10,244,392 | $3.3M | 40.5% |
| 13 | $0.26 | 1,514,100 | $394K | 4.9% |
| Total | $0.30 avg | 27,228,412 | $8.1M | 100% |